| Stephanie Speck Steinman, | |
|
1911 Towne Centre Blvd, Target 2271, Annapolis, MD 21401-3020 | |
| (443) 837-3541 | |
| Not Available |
| Full Name | Stephanie Speck Steinman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1911 Towne Centre Blvd, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427341692 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11490 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Speck Steinman, 1911 Towne Centre Blvd, Target 2271, Annapolis, MD 21401-3020 Ph: (443) 837-3541 | Stephanie Speck Steinman, 1911 Towne Centre Blvd, Target 2271, Annapolis, MD 21401-3020 Ph: (443) 837-3541 |
News Archive
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.
A study confirmed no differences in various measures of heart damage, according to cardiac magnetic resonance (MRI) imaging, in patients receiving the anti-clotting medication abxicimab directly into the heart (intracoronary) compared to those receiving it intravenously (IV).
Cyberbullying had the impact of amplifying symptoms of depression and post-traumatic stress disorder in young people who were inpatients at an adolescent psychiatric hospital, according to a new study published in the Journal of Clinical Psychiatry.
Researchers at New York University's Center for Comparative Functional Genomics and the University of California, Berkeley have used computational analyses to predict a genome-wide map of microRNA (miRNA) targets in the animal model organism, Caenorhabditis elegans (C. elegans).
For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the sequential use of single agent taxanes such as docetaxel and cabazitaxel. For example, docetaxel is commonly used as the "first-line" therapy, while cabazitaxel is used as the "second-line" therapy.
› Verified 6 days ago
Dr. Lawrence J Krebs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy, Ste 170, Annapolis, MD 21401 Phone: 410-573-6900 Fax: 410-573-1127 | |
Christie Dunton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy Ste G10, Annapolis, MD 21401 Phone: 443-481-5826 | |
Binal Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Annapolis, MD 21401 Phone: 410-295-3061 | |
Riyo Rajan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4157 | |
Jazzmine C Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 410-571-2090 Fax: 410-571-2896 | |
Margaret M Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4229 Fax: 443-481-4842 | |
Matthew Howard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Rd, Annapolis, MD 21403 Phone: 443-268-7688 Fax: 410-268-4597 |